BiotechTube

recombinant somatropin

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Infant, Small for Gestational Age

Conditions

Infant, Small for Gestational Age

Trial Timeline

Mar 1, 2009 → Dec 1, 2015

NCT ID
NCT01082354

About recombinant somatropin

recombinant somatropin is a pre-clinical stage product being developed by Merck for Infant, Small for Gestational Age. The current trial status is completed. This product is registered under clinical trial identifier NCT01082354. Target conditions include Infant, Small for Gestational Age.

Hype Score Breakdown

Clinical
5
Activity
2
Company
10
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT01082354Pre-clinicalCompleted

Competing Products

20 competing products in Infant, Small for Gestational Age

See all competitors
ProductCompanyStageHype Score
TSHA-101Taysha Gene TherapiesPhase 1/2
36
somatropinEli LillyPhase 3
77
Placebo + CisaprideJohnson & JohnsonApproved
85
RotaTeq (V260) + IPVMerckPhase 3
77
Recombinant human growth hormone (r-hGH)MerckPhase 3
77
MAS825 + PlaceboNovartisPhase 2
52
epoetin beta + epoetin betaRochePre-clinical
23
Genotropin (PN-180,307) Somatropin + Control-no treatmentPfizerPhase 3
76
Prevenar (13v)PfizerPre-clinical
22
rhBSSL + PlaceboSwedish Orphan BiovitrumPhase 2
51
rhBSSL + PlaceboSwedish Orphan BiovitrumPhase 2
51
DT5aP-IPV-Hib 5-component Pertussis vaccine + DT3aP-HBs-IPVSanofiPhase 3
76
alglucosidase alfa + alglucosidase alfaSanofiApproved
84
MyozymeSanofiPhase 2
51
Bacillus Clausii Multi ATB Resist + PlaceboSanofiApproved
84
RadiprodilUCBPhase 2
49
Larotrectinib (Vitrakvi, BAY2757556) + Standard of CareBayerPre-clinical
20
Sabril®LundbeckPre-clinical
20
VigabatrinLundbeckApproved
82
NusinersenBiogenPre-clinical
20

Other Products from Merck

DuleraApproved
85
ImipenemApproved
85
Mavenclad®Approved
85
raltegravir + PlaceboApproved
85
alendronate sodiumApproved
85